Investigations on the cytochrome P450 (CYP) isoenzymes involved in the metabolism of the designer drugs N-(1-phenyl cyclohexyl)-2-ethoxyethanamine and N-(1-phenylcyclohexyl)-2-methoxyethanamine-Reference-Cited by-同舟云学术

Investigations on the cytochrome P450 (CYP) isoenzymes involved in the metabolism of the designer drugs N-(1-phenyl cyclohexyl)-2-ethoxyethanamine and N-(1-phenylcyclohexyl)-2-methoxyethanamine

Published:2009-02 Issue:3 Volume:77 Page:444-450
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Sauer Christoph,Peters Frank T.,Schwaninger Andrea E.,Meyer Markus R.,Maurer Hans H.

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference32 articles.

1. Human cytochrome P450 enzymes;Guengerich,2005

2. The demethylenation of methylenedioxymethamphetamine (“ecstasy”) by debrisoquine hydroxylase (CYP2D6);Tucker;Biochem Pharmacol,1994

3. Interactions of amphetamine analogs with human liver CYP2D6;Wu;Biochem Pharmacol,1997

4. Neue synthetische drogen: piperazin- procyclidin- und alpha-aminopropiophenonderivate;Roesner;Toxichem Krimtech,1999

5. Synthesis of phencyclidine and other 1-arylcyclohexylamines;Maddox;J Med Chem,1965

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolism testing methods as exemplified by selected new psychoactive substances (NPSs);Problems of Forensic Sciences;2022-03-29

2. Appendix B: Metabolism of Major Illicit Drugs;Human Drug Metabolism;2020-02-21

3. New Psychoactive Substances 3-Methoxyphencyclidine (3-MeO-PCP) and 3-Methoxyrolicyclidine (3-MeO-PCPy): Metabolic Fate Elucidated with Rat Urine and Human Liver Preparations and their Detectability in Urine by GC-MS, “LC-(High Resolution)-MSn” and “LC-(High Resolution)-MS/MS”;Current Neuropharmacology;2017-06-15

4. Investigating Drug Metabolism of New Psychoactive Substances Using Human Liver Preparations and Animal Studies;Forensic Toxicology: Drug Use and Misuse;2016-07-14

5. Drugs of Abuse (Including Designer Drugs);Metabolism of Drugs and Other Xenobiotics;2012-06-04